发明申请
- 专利标题： TARGETED DELIVERY OF FACTOR VIII PROTEINS TO PLATELETS
- 专利标题（中）： 将要素VIII蛋白质指定给药片
-
申请号： US13262178申请日： 2010-04-06
-
公开(公告)号： US20120093840A1公开(公告)日： 2012-04-19
- 发明人: Henrik Østergaard , Anthony Pusateri , Thomas R. Barnett , Jens Buchardt , Bernd Peschke , Mikael Kofod-Hansen , Magali A. Zundel , Carsten Behrens , Eva H. Norling Olsen , Henning Stennicke
- 申请人： Henrik Østergaard , Anthony Pusateri , Thomas R. Barnett , Jens Buchardt , Bernd Peschke , Mikael Kofod-Hansen , Magali A. Zundel , Carsten Behrens , Eva H. Norling Olsen , Henning Stennicke
- 申请人地址： DK Bagsvaerd
- 专利权人： Novo Nordisk A/S
- 当前专利权人： Novo Nordisk A/S
- 当前专利权人地址： DK Bagsvaerd
- 国际申请： PCT/EP10/54495 WO 20100406
- 主分类号： A61K39/395
- IPC分类号： A61K39/395 ; C12P21/02 ; A61P7/04 ; C12N5/10 ; C07K19/00 ; C12N15/62
摘要：
The invention described herein relates to novel molecules and polypeptides comprising at least one amino acid sequence having significant identity with (homology to) human Factor VIII or biologically active portion(s) thereof, related molecules (such as nucleic acids encoding such polypeptides), compositions (such as pharmaceutical formulations) comprising such polypeptides, and methods of making and using such polypeptides.
信息查询
